Syros Pharmaceuticals (SYRS) Reaches $16.81 After 9.00% Down Move; Rwc Asset Management Llp Trimmed Its Ss&C Technologies Hldgs (SSNC) Stake

October 13, 2017 - By Adrian Mccoy

Rwc Asset Management Llp decreased Ss&C Technologies Hldgs Inc (SSNC) stake by 21.43% reported in 2017Q2 SEC filing. Rwc Asset Management Llp sold 75,000 shares as Ss&C Technologies Hldgs Inc (SSNC)’s stock rose 4.26%. The Rwc Asset Management Llp holds 275,000 shares with $10.56 million value, down from 350,000 last quarter. Ss&C Technologies Hldgs Inc now has $8.43B valuation. The stock declined 0.12% or $0.05 reaching $41.02 per share. About 226,296 shares traded. SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) has risen 26.42% since October 13, 2016 and is uptrending. It has outperformed by 9.72% the S&P500.

The stock of Syros Pharmaceuticals Inc (NASDAQ:SYRS) is a huge mover today! About 56,236 shares traded. Syros Pharmaceuticals Inc (NASDAQ:SYRS) has 0.00% since October 13, 2016 and is . It has underperformed by 16.70% the S&P500.The move comes after 5 months negative chart setup for the $441.43 million company. It was reported on Oct, 13 by Barchart.com. We have $15.30 PT which if reached, will make NASDAQ:SYRS worth $39.73 million less.

Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The company has market cap of $441.43 million. The Firm offers a gene control platform designed to analyze the unexploited region of deoxyribonucleic acid in human disease tissue to identify and drug targets linked to genomically defined patient populations. It currently has negative earnings. The Firm is focused on developing treatments for cancer and immune-mediated diseases and is building a pipeline of gene control medicines.

Analysts await Syros Pharmaceuticals Inc (NASDAQ:SYRS) to report earnings on November, 13. They expect $-0.53 EPS, up 18.46% or $0.12 from last year’s $-0.65 per share. After $-0.52 actual EPS reported by Syros Pharmaceuticals Inc for the previous quarter, Wall Street now forecasts 1.92% negative EPS growth.

Analysts await SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) to report earnings on October, 26. They expect $0.46 EPS, up 21.05% or $0.08 from last year’s $0.38 per share. SSNC’s profit will be $94.53M for 22.29 P/E if the $0.46 EPS becomes a reality. After $0.43 actual EPS reported by SS&C Technologies Holdings, Inc. for the previous quarter, Wall Street now forecasts 6.98% EPS growth.

Investors sentiment increased to 2.05 in 2017 Q2. Its up 0.81, from 1.24 in 2017Q1. It increased, as 24 investors sold SSNC shares while 51 reduced holdings. 64 funds opened positions while 90 raised stakes. 172.87 million shares or 0.83% less from 174.31 million shares in 2017Q1 were reported. 13,049 were accumulated by Ameriprise Fincl. Park Presidio Ltd Liability Com holds 4.33% or 700,000 shares. Sumitomo Mitsui accumulated 0.03% or 495,395 shares. Parallax Volatility Advisers LP has invested 0% of its portfolio in SS&C Technologies Holdings, Inc. (NASDAQ:SSNC). Msd Partners Limited Partnership invested in 6.81% or 2.85M shares. Peak6 LP reported 1,034 shares. State Street stated it has 3.01 million shares or 0.01% of all its holdings. Geneva Advsrs Lc has 0.64% invested in SS&C Technologies Holdings, Inc. (NASDAQ:SSNC). Sumitomo Mitsui Asset Mgmt Co holds 0.01% or 11,855 shares. Regions Finance Corporation invested in 0% or 7,198 shares. Gotham Asset Management Limited Co reported 0.14% stake. 372 are owned by Point72 Asia (Hong Kong) Limited. Of Vermont reported 77 shares or 0% of all its holdings. Raymond James & invested 0% of its portfolio in SS&C Technologies Holdings, Inc. (NASDAQ:SSNC). Citadel Advisors Ltd Liability reported 0.06% in SS&C Technologies Holdings, Inc. (NASDAQ:SSNC).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com